Phase I Study of Adoptive T-Cell Therapy Using Antigen-Specific CD8+ T Cells for the Treatment of Patients With Metastatic Melanoma

A Mackensen, N Meidenbauer, S Vogl… - Journal of Clinical …, 2006 - ascopubs.org
Purpose The adoptive transfer of in vitro generated tumor antigen-specific cytotoxic T
lymphocytes (CTL) provides a promising approach to the immunotherapy of cancer. A phase …
被引用次数：433 相关文章

Phase I Study of Adoptive T-Cell Therapy Using Antigen-Specific CD8+ T Cells for the Treatment of Patients With Metastatic Melanoma

A Mackensen, N Meidenbauer, S Vogl… - Journal of Clinical …, 2006 - cir.nii.ac.jp
抄録< jats: sec>< jats: title> Purpose</jats: title>< jats: p> The adoptive transfer of in vitro
generated tumor antigen-specific cytotoxic T lymphocytes (CTL) provides a promising …

Phase I study of adoptive T-cell therapy using antigen-specific CD8+ T cells for the treatment of patients with metastatic melanoma

A Mackensen, N Meidenbauer… - Journal of clinical …, 2006 - epub.uni-regensburg.de
PURPOSE: The adoptive transfer of in vitro generated tumor antigen-specific cytotoxic T
lymphocytes (CTL) provides a promising approach to the immunotherapy of cancer. A phase …
[PDF] researchgate.net

[PDF][PDF] Phase I Study of Adoptive T-Cell Therapy Using Antigen-Specific CD8 T Cells for the Treatment of Patients With Metastatic Melanoma

A Mackensen, N Meidenbauer, S Vogl, M Laumer… - J Clin …, 2006 - researchgate.net
Purpose The adoptive transfer of in vitro generated tumor antigen-specific cytotoxic T
lymphocytes (CTL) provides a promising approach to the immunotherapy of cancer. A phase …

Phase I study of adoptive T-cell therapy using antigen-specific CD8+ T cells for the treatment of patients with metastatic melanoma

A Mackensen, N Meidenbauer… - Journal of clinical …, 2006 - pubmed.ncbi.nlm.nih.gov
Purpose The adoptive transfer of in vitro generated tumor antigen-specific cytotoxic T
lymphocytes (CTL) provides a promising approach to the immunotherapy of cancer. A phase …
[PDF] psu.edu

[PDF][PDF] Phase I Study of Adoptive T-Cell Therapy Using Antigen-Specific CD8 T Cells for the Treatment of Patients With Metastatic Melanoma

A Mackensen, N Meidenbauer, S Vogl, M Laumer… - J Clin Oncol, 2006 - Citeseer
Purpose The adoptive transfer of in vitro generated tumor antigen-specific cytotoxic T
lymphocytes (CTL) provides a promising approach to the immunotherapy of cancer. A phase …

[引用][C] Phase I study of adoptive T-cell therapy using antigen-specific CD8+ T cells for the treatment of patients with metastatic melanoma

A MACKENSEN, N MEIDENBAUER… - Journal of clinical …, 2006 - pascal-francis.inist.fr
Phase I study of adoptive T-cell therapy using antigen-specific CD8+ T cells for the
treatment of patients with metastatic melanoma CNRS Inist Pascal-Francis CNRS Pascal …

Phase I study of adoptive T-cell therapy using antigen-specific CD8+ T cells for the treatment of patients with metastatic melanoma.

A Mackensen, N Meidenbauer, S Vogl… - Journal of Clinical …, 2006 - europepmc.org
Purpose The adoptive transfer of in vitro generated tumor antigen-specific cytotoxic T
lymphocytes (CTL) provides a promising approach to the immunotherapy of cancer. A phase …

[引用][C] Phase I study of adoptive T-cell therapy using antigen-specific CD8+ T cells for the treatment of patients with metastatic melanoma

A MACKENSEN - J Clin Oncol, 2006 - cir.nii.ac.jp
Phase I study of adoptive T-cell therapy using antigen-specific CD8+ T cells for the treatment of
patients with metastatic melanoma | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ …

[引用][C] Phase I study of adoptive T-cell therapy using antigen-specific CD8+ T cells for the treatment of patients with metastatic melanoma

A MACKENSEN… - Journal of …, 2006 - American Society of Clinical …